专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US08835163B2 Embryonic-like stem cells derived from adult human peripheral blood and methods of use 有权
标题翻译：胚胎样干细胞源自成年人外周血和使用方法
公开(公告)号：US08835163B2
公开(公告)日：2014-09-16
申请号：US12445505
申请日：2007-10-18
申请人： Yong Zhao , Theodore Mazzone
发明人： Yong Zhao , Theodore Mazzone
IPC分类号： C12N5/10 , A61K35/14 , C12N5/071 , A61K35/54 , C12N5/074 , C12N5/078 , A61K35/39 , A61K35/12
CPC分类号： C12N5/0607 , A61K35/17 , A61K35/39 , A61K35/545 , A61K2035/122 , C12N5/0634 , C12N5/0676 , C12N2500/34 , C12N2501/22 , C12N2501/335 , C12N2506/03
摘要： The present invention is related generally to embryonic-like stem cells isolated from adult human peripheral blood, designated herein as peripheral blood-stem cells (PB-SC), which display the characteristics of embryonic stem cells and hematopoietic cells. These cells have the capability of proliferation and are able to differentiate to other types of cells. These cells are, therefore, suitable for use in stem cell-based therapies, particularly autologous stem cell therapies, for the treatment of various diseases such as neurodegenerative diseases, autoimmune diseases, diabetes, spinal cord damage, multiple sclerosis, cardiovascular disease, stroke and birth defects.
摘要翻译：本发明一般涉及从成人外周血分离的胚胎样干细胞，本文命名为外周血干细胞（PB-SC），其显示胚胎干细胞和造血细胞的特征。这些细胞具有增殖能力，能够区分到其他类型的细胞。因此，这些细胞适合用于基于干细胞的治疗，特别是自体干细胞治疗，用于治疗各种疾病，例如神经退行性疾病，自身免疫性疾病，糖尿病，脊髓损伤，多发性硬化，心血管疾病，中风和出生缺陷。

2. 发明申请

US20070059824A1 Human umbilical cord blood-derived pluripotent fibroblast-like-macrophages 审中-公开
标题翻译：人脐带血源性多能成纤维细胞样巨噬细胞
公开(公告)号：US20070059824A1
公开(公告)日：2007-03-15
申请号：US11519307
申请日：2006-09-12
申请人： Yong Zhao , Theodore Mazzone
发明人： Yong Zhao , Theodore Mazzone
IPC分类号： C12N5/08
CPC分类号： C12N5/0647 , C12N5/0607 , C12N5/0676 , C12N2500/34 , C12N2501/052 , C12N2501/145 , C12N2501/22 , C12N2506/03 , C12N2506/11
摘要： The present invention relates to a purified population of fibroblast-like macrophage (f-macrophage, f-MΦ) and methods using the same. The f-MΦ can be expanded in vitro and differentiated into several lineages, including insulin-expressing cells, endothelial cells, and neuronal cells. The f-MΦ described herein have been generated from human umbilical cord blood (CB f-MΦ) and have characteristics similar to f-MΦ derived from peripheral blood. Thrombopoietin (TPO), at low dosage, significantly stimulates the proliferation of CB f-MΦ, wherein the TPO-expanded CB f-MΦ retain their pluripotent differentiation potential.
摘要翻译：本发明涉及纯化的成纤维细胞样巨噬细胞群（f-巨噬细胞，f-MPhi）和使用其的方法。 f-MPhi可以在体外扩增并分化成几个谱系，包括表达胰岛素的细胞，内皮细胞和神经元细胞。本文描述的f-MPhi已经由人脐带血（CB f-MPhi）产生并且具有与来自外周血的f-MPhi相似的特征。血小板生成素（TPO）以低剂量显着刺激CB f-MPhi的增殖，其中TPO扩张的CB f-MPhi保留其多能分化潜能。

3. 发明授权

US09388382B2 Isolation of CD14 negative, CD45 positive and CD117 positive embryonic-like stem cells free of monocytes from human umbilical cord blood mononuclear cells 有权
标题翻译：分离CD14阴性，CD45阳性和CD117阳性胚胎样干细胞免于人脐带血单核细胞单核细胞
公开(公告)号：US09388382B2
公开(公告)日：2016-07-12
申请号：US12099054
申请日：2008-04-07
申请人： Yong Zhao , Theodore Mazzone
发明人： Yong Zhao , Theodore Mazzone
IPC分类号： C12N5/00 , C12N5/074 , A61K35/12
CPC分类号： C12N5/0607 , A61K2035/122
摘要： The present invention is related generally to embryonic-like stem cells isolated from human umbilical cord blood, designated herein as cord blood-stem cells (CB-SC's), which display the characteristics of embryonic stem cells and hematopoietic cells. These cells have the capability of proliferation and are able to differentiate to multiple types of cells. In addition, the CB-SC display low immunogenicity and immune regulation. These cells are, therefore, suitable for use in stem cell-based therapies for the treatment of diseases such as Parkinson's disease, diabetes, spinal cord damage, multiple sclerosis, cardiovascular disease, stroke and birth defects, and for preventing, treating and/or reducing an autoimmune disease in a mammalian subject.
摘要翻译：本发明一般涉及从人脐带血分离的胚胎样干细胞，本文称为脐带血干细胞（CB-SC），其显示胚胎干细胞和造血细胞的特征。这些细胞具有增殖能力，能够分化成多种类型的细胞。此外，CB-SC显示低免疫原性和免疫调节。因此，这些细胞适合用于治疗诸如帕金森病，糖尿病，脊髓损伤，多发性硬化，心血管疾病，中风和出生缺陷的疾病的基于干细胞的疗法，以及用于预防，治疗和/ 减少哺乳动物受试者的自身免疫性疾病。

4. 发明申请

US20100129440A1 EMBRYONIC-LIKE STEM CELLS DERIVED FROM ADULT HUMAN PERIPHERAL BLOOD AND METHODS OF USE 有权
标题翻译：来自成人人外周血的胚胎干细胞和使用方法
公开(公告)号：US20100129440A1
公开(公告)日：2010-05-27
申请号：US12445505
申请日：2007-10-18
申请人： Yong Zhao , Theodore Mazzone
发明人： Yong Zhao , Theodore Mazzone
IPC分类号： A61K9/48 , C12N5/02 , C12N5/071 , A61K35/12
CPC分类号： C12N5/0607 , A61K35/17 , A61K35/39 , A61K35/545 , A61K2035/122 , C12N5/0634 , C12N5/0676 , C12N2500/34 , C12N2501/22 , C12N2501/335 , C12N2506/03
摘要： The present invention is related generally to embryonic-like stem cells isolated from adult human peripheral blood, designated herein as peripheral blood-stem cells (PB-SC), which display the characteristics of embryonic stem cells and hematopoietic cells. These cells have the capability of proliferation and are able to differentiate to other types of cells. These cells are, therefore, suitable for use in stem cell-based therapies, particularly autologous stem cell therapies, for the treatment of various diseases such as neurodegenerative diseases, autoimmune diseases, diabetes, spinal cord damage, multiple sclerosis, cardiovascular disease, stroke and birth defects.
摘要翻译：本发明一般涉及从成人外周血分离的胚胎样干细胞，本文命名为外周血干细胞（PB-SC），其显示胚胎干细胞和造血细胞的特征。这些细胞具有增殖能力，能够区分到其他类型的细胞。因此，这些细胞适合用于基于干细胞的治疗，特别是自体干细胞治疗，用于治疗各种疾病，例如神经退行性疾病，自身免疫性疾病，糖尿病，脊髓损伤，多发性硬化，心血管疾病，中风和出生缺陷。

5. 发明申请

US20090175832A1 Isolated Embryonic-Like Stem Cells Derived From Human Umbilical Cord Blood 有权
标题翻译：分离的胚胎样干细胞源自人类脐带血
公开(公告)号：US20090175832A1
公开(公告)日：2009-07-09
申请号：US12099054
申请日：2008-04-07
申请人： YONG ZHAO , THEODORE MAZZONE
发明人： YONG ZHAO , THEODORE MAZZONE
IPC分类号： A61K45/00 , C12N5/08 , A61P3/10
CPC分类号： C12N5/0607 , A61K2035/122
摘要： The present invention is related generally to embryonic-like stem cells isolated from human umbilical cord blood, designated herein as cord blood-stem cells (CB-SC's), which display the characteristics of embryonic stem cells and hematopoietic cells. These cells have the capability of proliferation and are able to differentiate to multiple types of cells. In addition, the CB-SC display low immunogenicity and immune regulation. These cells are, therefore, suitable for use in stem cell-based therapies for the treatment of diseases such as Parkinson's disease, diabetes, spinal cord damage, multiple sclerosis, cardiovascular disease, stroke and birth defects, and for preventing, treating and/or reducing an autoimmune disease in a mammalian subject.
摘要翻译：本发明一般涉及从人脐带血分离的胚胎样干细胞，本文称为脐带血干细胞（CB-SC），其显示胚胎干细胞和造血细胞的特征。这些细胞具有增殖能力，能够分化成多种类型的细胞。此外，CB-SC显示低免疫原性和免疫调节。因此，这些细胞适合用于治疗诸如帕金森病，糖尿病，脊髓损伤，多发性硬化，心血管疾病，中风和出生缺陷的疾病的基于干细胞的疗法，以及用于预防，治疗和/ 减少哺乳动物受试者的自身免疫性疾病。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式